Global Human Chorionic Gonadotropin (hCG) Market

1. Summary

The Global Human Chorionic Gonadotropin (hCG) Market was valued at $1.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.2% CAGR, to an estimated market size of $1.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The Human Chorionic Gonadotropin (hCG) market encompasses the production, distribution, and clinical application of the glycoprotein hormone primarily utilized in assisted reproductive technology (ART) for ovulation induction and oocyte maturation. The scope includes therapeutic use for endocrine disorders such as male hypogonadotropic hypogonadism and cryptorchidism, as well as diagnostic applications for pregnancy testing and oncology biomarkers, while excluding unverified off-label uses for weight loss.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Human Chorionic Gonadotropin (hCG) Market in the period 2025-30:

• The rising global prevalence of infertility, now affecting approximately 1 in 6 adults, serves as the primary catalyst for increased hCG utilization in fertility treatments.
• A major industry shift is occurring from traditional urinary-derived formulations to recombinant hCG, which offers superior purity, batch-to-batch consistency, and reduced pathogen risk.
• Demographic shifts toward delayed parenthood and advanced maternal age are significantly increasing the volume of IVF cycles and the subsequent demand for hormonal triggers.
• The integration of Artificial Intelligence is revolutionizing the market by optimizing drug discovery processes and enhancing the accuracy of real-time patient monitoring during ART cycles.
• Expanding therapeutic applications for male hypogonadism and oligospermia are diversifying the market beyond female fertility, driven by rising rates of obesity and metabolic disorders.
• The growth of medical tourism in the Asia-Pacific region is boosting regional market shares as patients seek cost-effective and high-quality fertility services across borders.
• The proliferation of tele-fertility services and advanced home-based quantitative testing kits is improving patient accessibility and driving the diagnostic segment of the market.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: